We are live on ! Find out more
CEROW

CERo Therapeutics Warrants
CEROW

Delisted

CEROW was delisted on the 30th of October, 2025.

Back to rankings

23 hedge funds and large institutions have $74.5K invested in CERo Therapeutics Warrants in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

63% more capital invested

Capital invested by funds: $45.7K → $74.5K (+$28.9K)

32.65% more ownership

Funds ownership: 2.26% → 34.91% (+33%)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

12% less funds holding

Funds holding: 26 → 23 (-3)

50% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 6

Holders
23
Holders Change
-3
Holders Change %
-11.54%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
1
Closed
6
Calls
$3K
Puts
–
Net Calls
+$3K
Net Calls Change
+$1K

Top Buyers

Rank Fund Capital Flow
1
Toronto Dominion Bank
Toronto Dominion Bank
Ontario, Canada
+$5.91K
2
CS
Clear Street
New York
+$766
3
VF
Virtu Financial
New York
+$317
4
FFS
Fortress Financial Solutions
Arizona
+$155

Top Sellers

Rank Fund Capital Flow
1
PC
Periscope Capital
Ontario, Canada
-$3.97K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$2.8K
3
YCM
Yakira Capital Management
Connecticut
-$725
4
RCM
Rivernorth Capital Management
Florida
-$362
5
SSA
Schonfeld Strategic Advisors
New York
-$217
Name Holding Trade Value Shares
Change 		Change in
Stake
CF
1
Cantor Fitzgerald
New York
$10.5K – – –
Toronto Dominion Bank
2
Toronto Dominion Bank
Ontario, Canada
$9.07K +$5.91K +381,318 New
MI
3
MMCAP International
Cayman Islands
$8.93K – – –
SCM
4
Saba Capital Management
New York
$7.04K – – –
CSD
5
Clear Street Derivatives
New York
$6.38K – – –
LA
6
Linden Advisors
New York
$5.72K – – –
BOCH
7
Blue Owl Capital Holdings
New York
$5.35K – – –
CS
8
Clear Street
New York
$4.61K +$766 +49,399 +34%
QGA
9
Q Global Advisors
Texas
$4K – – –
CCM
10
Context Capital Management
California
$2.9K – – –
NAM
11
Nexpoint Asset Management
Texas
$2.59K – – –
WCMNY
12
Westchester Capital Management (New York)
New York
$1.57K – – –
PA
13
Parallel Advisors
California
$1.19K – – –
TCM
14
Tenor Capital Management
New York
$1.19K – – –
PMAM
15
Picton Mahoney Asset Management
Ontario, Canada
$1K – – –
WAM
16
Wolverine Asset Management
Illinois
$804 -$155 -10,000 -23%
WA
17
Whitebox Advisors
Minnesota
$554 – – –
SRF
18
Silver Rock Financial
California
$291 – – –
Calamos Advisors
19
Calamos Advisors
Illinois
$263 – – –
DCM
20
Dupont Capital Management
Delaware
$263 – – –
FFS
21
Fortress Financial Solutions
Arizona
$238 +$155 +10,000 New
AA
22
Ancora Advisors
Ohio
$59 – – –
PC
23
Periscope Capital
Ontario, Canada
– -$3.97K -274,000 Closed
Susquehanna International Group
24
Susquehanna International Group
Pennsylvania
– -$2.8K -192,874 Closed
YCM
25
Yakira Capital Management
Connecticut
– -$725 -49,999 Closed
1
2

CEROW Hedge Fund Activity: Q2 2025 in Review

23 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in CERo Therapeutics Warrants (CEROW) for Q2 2025, worth a combined $74.5K — up 63% from $45.7K a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of CEROW and 3 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 1 added.

The largest buyer was Toronto Dominion Bank, opening a new position worth an estimated $5.91K. The largest seller was Periscope Capital, exiting entirely with an estimated $3.97K sold.

  • 23 institutional investors held CERo Therapeutics Warrants (CEROW) as of Q2 2025, down from 26 in Q1 2025.
  • Funds reported $74.5K of CERo Therapeutics Warrants stock for Q2 2025, up 63% quarter-over-quarter.
  • 3 funds opened new CERo Therapeutics Warrants positions in Q2 2025 and 6 closed out, a net change of -3 holders.
  • The largest CERo Therapeutics Warrants buyer in Q2 2025 was Toronto Dominion Bank, an estimated $5.91K added.
  • The largest CERo Therapeutics Warrants seller in Q2 2025 was Periscope Capital, an estimated $3.97K sold.

Based on aggregated 13F filings for Q2 2025.